NCT00056667

Brief Summary

This study will evaluate the relative effectiveness of Relaxation Response (RR) training for the treatment of rheumatoid arthritis (RA). The study will compare RR training to RR training with cognitive behavioral therapy and to a standard RA education program.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
168

participants targeted

Target at P50-P75 for phase_4 rheumatoid-arthritis

Timeline
Completed

Started Jul 2001

Longer than P75 for phase_4 rheumatoid-arthritis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2001

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

March 20, 2003

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 24, 2003

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2006

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2006

Completed
Last Updated

January 17, 2014

Status Verified

January 1, 2014

Enrollment Period

5.4 years

First QC Date

March 20, 2003

Last Update Submit

January 15, 2014

Conditions

Keywords

TreatmentPainRelaxation ResponseCognitive Behavioral Therapy

Outcome Measures

Primary Outcomes (1)

  • Somatic symptoms as assessed by the Rheumatoid Arthritis Symptom Questionnaire

    12 months

Secondary Outcomes (2)

  • Role impairment and functional status as assessed with the Functional Status Questionnaire

    12 months

  • Medical care utilization as assessed with the hospital's automated encounter database

    12 months

Study Arms (3)

CBT plus relaxation response

EXPERIMENTAL

Participants will receive cognitive behavioral therapy plus relaxation response training

Behavioral: Relaxation response and cognitive behavioral therapy

Relaxation Response

ACTIVE COMPARATOR

Participants will receive relaxation response training

Behavioral: Relaxation response

Education

PLACEBO COMPARATOR

Participants will receive rheumatoid arthritis education

Other: RA education

Interventions

The cognitive behavioral therapy program wwill incorporate relaxation training, a modified version of the RA treatment program developed by Bradley et al (1987) and shown to be effective. The cognitive behavioral techniques include problem solving, relabeling, enhanced awareness of pain behaviors, and attention refocusing. The RR component includes instruction in diaphragmatic breathing along with progressive skeletal muscle relaxation. The intervention will be modified from the original program in that neither biofeedback training nor participation of family members will be included. Consequently, the number of weekly group sessions will be reduced from 14 to 12. Homework will be given at the end of each session, to be completed and brought in for review to the next session.

Also known as: RRCBT
CBT plus relaxation response

The relaxation response (RR) consists of a set of integrated physiological changes elicited when a participant engages in the repetitive mental action of focusing on a word, phrase, or image, while passively ignoring distracting thoughts. These changes include decreased oxygen consumption, heart rate, arterial blood pressure, respiratory rate, and arterial blood lactate, along with slight increases in skeletal muscle blood flow. The long-term physiologic changes of participants eliciting the relaxation response are consistent with reduced norepinephrine end organ responsivity. These latter changes provide a plausible psychophysiological mechanism for longer-term actions of the RR.

Also known as: RR
Relaxation Response

RA education programs have been widely used to supplement routine medical care. They have been found to be of modest benefit, particularly in terms of knowledge about the condition and its treatment. The long-term effects on pain and level of function are less. When used as an attention control, such educational programs have been found to be as credible and as well attended as the active experimental treatment (Professor Francis Keefe, Personal Communication). In this study, patients randomized to the control condition will receive 8 weekly sessions of RA education, in groups of 6-10 patients each, using portions of the Arthritis Self-Management Program and incorporating printed and videotaped materials available from the Arthritis Foundation.

Education

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • RA as defined by the American College of Rheumatology
  • English literacy and fluency

You may not qualify if:

  • Major medical condition or illness which limits life expectancy or results in severe symptoms or functional disability (Duke Severity of Illness score \> 0.85)
  • Fibromyalgia
  • Received or currently receiving psychosocial treatment for RA
  • Unavailability for Month 12 follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brigham & Women's Hospital

Boston, Massachusetts, 02115, United States

Location

Related Publications (1)

  • Barsky AJ, Ahern DK, Orav EJ, Nestoriuc Y, Liang MH, Berman IT, Kingsbury JR, Sy JT, Wilk KG. A randomized trial of three psychosocial treatments for the symptoms of rheumatoid arthritis. Semin Arthritis Rheum. 2010 Dec;40(3):222-32. doi: 10.1016/j.semarthrit.2010.04.001.

MeSH Terms

Conditions

Arthritis, RheumatoidPain

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Arthur J. Barsky, MD

    Brigham & Women's Hospital, Boston, MA

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vice Chair for Research

Study Record Dates

First Submitted

March 20, 2003

First Posted

March 24, 2003

Study Start

July 1, 2001

Primary Completion

December 1, 2006

Study Completion

December 1, 2006

Last Updated

January 17, 2014

Record last verified: 2014-01

Locations